Tag: classical hodgkin lymphoma

Nivolumab+AVD Improves Survival in Advanced Classic Hodgkin’s Lymphoma Compared to Brentuximab Vedotin+AVD

byAngel Gaoand1 others

October 30, 2024

#VisualAbstract: Adolescents had an increased risk of all-cause mortality over younger children with Hodgkin lymphoma

byKathleen Lau

January 20, 2022

$#VisualAbstract Brentuximab vedotin with nivolumab was well-tolerated and showed durable remissions as initial salvage therapy in relapsed/refractory classic Hodgkin’s Lymphoma$

#VisualAbstract Brentuximab vedotin with nivolumab was well-tolerated and showed durable remissions as initial salvage therapy in relapsed/refractory classic Hodgkin’s Lymphoma

byKathleen Lau

August 20, 2021

#VisualAbstract Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in untreated early unfavourable and advanced stage classical Hodgkin lymphoma

byKathleen Lau

March 25, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result